Drug companies rubbing their hands with glee at the ‘discovery’ of three new mental illnesses?

Leave a comment

July 29, 2010 by sharonbrennan

This week the American Psychiatric Association (APA) announced the updated fifth edition of their Diagnostic and Statistical Manual of Mental Disorders (DSM) and it appears they have identified three new illnesses: “mixed anxiety depression, psychosis risk syndrome and temper dysregulation disorder.”

My only experience with mental illness is as follows: I was having a pretty shit day because I couldn’t breath. I think feeling miserable about that is a pretty bog-standard normal reaction. I happened to be going to the doctors to update my prescription list and he said I looked rather down and did I think I was depressed and started asking me if I ever felt low or cried for no reason. Which made me cry.

So there he is thinking I’m depressed when actually I was only crying because I found the whole situation confusing and I was scared that maybe I was depressed and hadn’t noticed it, which confused me even more. Anyway I turned down his suggestion of some mild anti-depressants but it completely shocked me at the ease that these drugs can be obtained. I mean, Jesus, girls cry all the time, it’s just our way of venting frustration.

So of the new illnesses outlined in the APAs’ manual lets just think about psychosis risk syndrome. By the psychiatric association’s own admission this isn’t even an illness. Its basically saying to someone they’re at risk of developing a mental illness because they’re experiencing abrupt personality changes. And from experience, someone telling you you might be mentally ill is incredibly stressful, and truly makes you question your sanity. There is a great article outlining the effects of over-diagnosis here.

So what’s the point of the APA’s manual? Well give this some thought:
“The US Senate Finance Committee has investigated at least 16 APA psychiatrists over their undisclosed financial ties to drug companies, including the APA’s own President, Alan Schatzberg who has stepped down as principal investigator of a National Institute of Health (NIH) funded study after months of Congressional scrutiny into his ties to the drug he was studying.  He was found to have actually initiated the patent application of the drug he was studying to “treat psychotic depression.” You can read more about this here.

Another investigation published in April last year by people working for three major US universities, including Harvard medical school, found :
“Ninety percent of the authors of 3 major clinical practice guidelines in psychiatry had financial ties to companies that manufacture drugs which were explicitly or implicitly identified in the guidelines as recommended therapies for the respective mental illnesses. None of the financial associations of the authors were disclosed in the clinical practice guidelines.”

Drug companies make shed loads from selling drugs. In 2007 it was estimated that drug company GlaxoSmithKline made £1 billion per year in profit from anti-depressant Seroxat. According to Forbes, at its peak, drug company Eli Lilly made $3 billion dolllar profits from Prozac in 2000 (profits fell subsequently when it lost its patent protection).

So the more illnesses that can be discovered, the more drugs can be invented to cure it. And more over, as the drop in profit from Prozac shows, there is a continual need for new drugs to be created as a drug company’s patent only lasts a prescribed period of time before it must give up its secrets to a generic drug maker.

No wonder there is a concern over the conflict of interest between APA members and drug companies.

And although it’s a US manual the DSM is used worldwide as a basis for diagnosis, research and medical education. I’m not saying that your local GP has a conspiracy going with GSK but a recent study by Rethink reveals that over two-thirds of GP’s don’t feel equipped to take responsibility for mental health – perhaps indicating they might rely on the APA’s mental health ‘bible’ more than they should?

Patients are being offered antidressants or other drugs for mental illness when they’re normally at they’re lowest ebb, and most likely to doubt their own opinions, especially when they conflict with those of a doctor. But don’t feel that drugs are your only option. Ask about therapy, counselling, the documented benefits of exercise in helping mental illness. Rest and exercise may create zero profit for a drug company but they can be fantastically valuable to a patient.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

Contact

+44 7789 378 605
sharon_brennan@hotmail.co.uk

  • 5,391
%d bloggers like this: